Log in
Enquire now
‌

Metrolaser, Inc. SBIR Phase II Award, May 2021

A SBIR Phase II contract was awarded to Metrolaser, Inc. in May, 2021 for $1,599,953.0 USD from the U.S. Department of Energy.

OverviewStructured DataIssuesContributors

Contents

sbir.gov/node/2103799
Is a
SBIR/STTR Awards
SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient
Metrolaser, Inc.
Metrolaser, Inc.
0
Government Agency
U.S. Department of Energy
U.S. Department of Energy
0
Award Type
SBIR0
Contract Number (US Government)
DE-SC00205270
Award Phase
Phase II0
Award Amount (USD)
1,599,9530
Date Awarded
May 3, 2021
0
End Date
May 2, 2023
0
Abstract

New instrumentation and bioimaging devices are required for viewing key metabolic processes in living organisms among microbial communities in plant environments. Small footprint devices are needed to make in situ, nondestructive, functional, and quantitative measurement independent of large, expensive instruments. These must also be affordable, deployable, and accessible to the larger scientific community. An affordable, low footprint digital holographic microscope will be built to satisfy the stated measurement requirement by exploiting unique features of holography, to remove key limitations in existing bioimaging systems and enable imaging and measuring key metabolic processes within and among microbial cells and multicellular plant tissues. Digital holograms can now be recorded on small, lightweight sensor arrays at video rates, processed in real time, and offer the many advantages associated with digital media, transferring much of the overall optical process into electronics and software. A hologram records all optical information in a light wave scattered from, transmitted through, or reflected from a biological surface of interest, enabling dynamic, microscopic imaging over large fields of view and depths of field with a relatively small instrument, capabilities that cannot be achieved with conventional imaging devices. Phase I demonstrated, experimentally and theoretically, the capability of digital holographic microscopy to record and measure typical critical parameters of biological cells, their movements, and changes in time, employing a flexible and controllable simulated biological system to refine, qualify, and characterize the measurement system and identify critical issues. Phase II will include constructing a refined portable digital holographic system and software initiated during Phase I and research on live biological samples and rhizosphere problems with a team consisting of microbiologists that are actively involved in this field. The system potential in biological research will be demonstrated and compared with conventional imaging tools. Digital holographic microscopy should have significant applications in industrial processes and biological research, where speed is at a particularly high premium. As an example, the semiconductor industry is a particularly attractive target. The proposed system differs from available systems and provides a flexible mix of spatial resolution, angular resolution, throughput, field of view, penetration depth and phase sensitivity by taking digital microscopy to a new level. Software developed in this research can be adapted to existing commercial systems providing many enhancements to such systems.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Metrolaser, Inc. SBIR Phase II Award, May 2021

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.